TWINLAB CORP
SC 13G, 1997-02-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: E TRADE GROUP INC, 10-Q, 1997-02-14
Next: TWINLAB CORP, SC 13G, 1997-02-14



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549





                                  SCHEDULE 13G


             INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934



                               Twinlab Corporation
                                (Name of Issuer)



                          Common Stock, $1.00 par value
                         (Title of Class of Securities)



                                   901774 10 9
                                 (CUSIP Number)


                                Page 1 of  5  Pages


<PAGE>

                                                                SCHEDULE 13G
                                                            Page 2 of  5 Pages

CUSIP No.   901774 10 9
- --------------------------------------------------------------------------------
1)       NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  Dean Blechman

- --------------------------------------------------------------------------------
2)       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP            (a)     [ ]

                                                                     (b)     [ ]

- --------------------------------------------------------------------------------
3)       SEC USE ONLY


- --------------------------------------------------------------------------------
4)       CITIZENSHIP OR PLACE OF ORGANIZATION

                  United States of America

- --------------------------------------------------------------------------------
                               5)     SOLE VOTING POWER
                                      1,660,080
         NUMBER
         OF                    6)     SHARED VOTING POWER
         SHARES                       N/A
         BENEFICIALLY
         OWNED BY              7)     SOLE DISPOSITIVE POWER
         EACH                         1,660,080
         REPORTING
         PERSON                8)     SHARED DISPOSITIVE POWER
         WITH                         N/A

- --------------------------------------------------------------------------------
9)       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         1,660,080

- --------------------------------------------------------------------------------
10)      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
         SHARES                                                         [ ]

- --------------------------------------------------------------------------------
11)      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
         6.1%

- --------------------------------------------------------------------------------
12)      TYPE OF REPORTING PERSON
                  IN


<PAGE>

Item 1(a). Name of Issuer:

         Twinlab Corporation

Item 1(b). Address of Issuer's Principal Executive Offices:

         2120 Smithtown Avenue, Ronkonkoma, NY  11779

Item 2(a). Name of Person Filing:

         Dean Blechman

Item 2(b).  Address of Principal Business Office or, if None, Residence:

         2120 Smithtown Avenue, Ronkonkoma, NY  11779

Item 2(c).  Citizenship:

         United States of America

Item 2(d).  Title of Class of Securities:

         Common Stock, $1.00 par value  (the "Common Stock")

Item 2(e).   CUSIP Number:

         901774 10 9

Item 3. If this  statement  is filed  pursuant to Rules  13d-1(b),  or 13d-2(b),
        check whether the person filing is a:

              Not applicable

Item 4. Ownership.


         (a)  Amount beneficially owned:  1,600,080 shares
         (b)  Percent of class:  6.1%
         (c)  Number of shares as to which filer has:
        


                                Page 3 of 5 Pages


<PAGE>

         (i) Sole power to vote or to direct the vote:

               1,600,080

         (ii) Shared power to vote or to direct the vote:

               Not Applicable

         (iii) Sole power to dispose or to direct the disposition of:

               1,600,080

         (iv)  Shared  power to  dispose  or to direct  the  disposition  of:

               Not Applicable

               Of such 1,600,080  shares,  834 are  beneficially  owned by minor
               children  of Mr.  Blechman.  Mr.  Blechman  disclaims  beneficial
               ownership  of such  securities  beneficially  owned by his  minor
               children.

Item 5.  Ownership of Five Percent or Less of a Class.

         Not applicable

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

         Not applicable

Item 7.  Identification  and Classification of the Subsidiary Which Acquired the
         Security Being Reported on by the Parent Holding Company.

         Not applicable

Item 8.  Identification and Classification of Members of the Group.

         Not applicable

Item 9.  Notice of Dissolution of Group.

         Not applicable

Item 10. Certification.

         Not applicable


                                Page 4 of 5 Pages


<PAGE>


                                    SIGNATURE


         After  reasonable  inquiry and to the best  knowledge and belief of the
undersigned,  the  undersigned  certifies that the information set forth in this
Statement is true, complete and correct.


Dated:  February 14, 1997



                                                     /s/ Dean Blechman 
                                                     ------------------ 
                                                     Name:  Dean Blechman


                                Page 5 of 5 Pages




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission